Catalent Pharma, Sanwa Kagaku Kenkyusho Co. Ltd. sales and marketing update

Sanwa granted Catalent exclusive rights to commercialize OSDrC optimized dose delivery technology outside of Japan, Korea, China and Taiwan. Sanwha already markets the technology, which enables the de...